HBOT-India unveils medical-grade hyperbaric oxygen therapy in Gurugram

August 19, 2022 | Friday | News

Adding hyperbaric oxygen therapy to the standard of care reduces the risk of major amputation by approx 20-30 per cent

Image credit: https://hbot-india.com/

Image credit: https://hbot-india.com/

HBOT-India has launched one of the first medical-grade hyperbaric oxygen therapy in Gurugram, Delhi NCR. Adding hyperbaric oxygen therapy to the standard of care reduces the risk of major amputation by approx 20-30 per cent and increases wound healing rate by 9-10 times. Further benefits of hyperbaric oxygen are not just limited to diabetic foot ulcer treatment but stretch wider into many diseases and conditions.

Dr Mandeep Singh Malhotra, Surgical Oncologist (Clinical Lead & Mentor – Art of Healing Cancer- AOHC) suggests as per research that in a single hour of HBOT treatment, the body takes in approximately about 2.4 pounds of oxygen into the tissue and this increased oxygen benefits by
  

  • Increase oxygen delivery to tissues with compromised blood flow such as diabetic foot ulcers, stroke, trauma, flaps, necrotic tissue in cancer, etc.
  • Decreases swelling and inflammation by deactivation of toxins; Increases the ability of the body’s immune cells to fight off infections.
  • Stimulates new blood vessels and capillary growth that aid in wound healing and also removal of toxins and waste products.
  • Increases the active firing of nerve cells thus helping in neural recovery.

    Hyperbaric Oxygen Therapy has documented benefits in many diseases like:

        
  • Diabetic foot ulcers
  • Wound healing
  • Severe anaemia
  • Delayed radiation injury or radiation necrosis
  • Traumatic Brain Injury
  • Gangrene
  • Compromised Grafts & Flaps
  •  Vision loss or sudden hearing loss
  • Brain Abscess

There are certain other conditions in which HBOT is likely to benefit:
 

  • Brain stroke
  • Brain-related disorders like Alzheimer, Paralysis, Parkinson’s, Brain Fog, etc
  • Refractory cancers which do not respond to chemotherapy.


     

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy